Concepedia

Masoud Azizad

MA

11

Publications

1.3K

Citations

11

H-Index

2002

Active since

Affiliations

Massachusetts General Hospital(Current)

Harvard University

University of Washington

Baylor University Medical Center

Cedars-Sinai Medical Center

Masoud Azizad is an author at Massachusetts General Hospital specializing in medicine, pharmacotherapy, and pharmacology.

Top concepts

Publications per year

2002–2024

11

Publications

11

A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus

William A. Fischer, Joseph J. Eron, Wayne Holman et al. · Science Translational Medicine · 2021 · 348 citations · Full text

Molnupiravir, an Oral Antiviral Treatment for COVID-19

William A. Fischer, Joseph J. Eron, Wayne Holman et al. · 2021 · 215 citations · Full text

Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial

Katherine R. Tuttle, Sibylle J. Hauske, María Eugênia Fernandes Canziani et al. · The Lancet · 2023 · 151 citations · Full text

, , +10

Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia

Christie M. Ballantyne, Szilárd Vasas, Masoud Azizad et al. · New England Journal of Medicine · 2024 · 151 citations

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 112 citations · Full text

Rows per page

1–5 of 11